Results 221 to 230 of about 16,868 (267)

Cardiotoxicity adverse outcome pathway network: towards mechanistic and quantitative modelling. [PDF]

Front Toxicol
Ladeira L, Barnes DA, Masereeuw R, Geris L, Staumont B.   +4 more
europepmc   +1 more source

Prevalence of MSI‐H/dMMR Colorectal Cancer in Japan: Data From the Clinical Study Group of the University of Osaka‐Colorectal Registry

Annals of Gastroenterological Surgery, EarlyView.
Using a multicenter Japanese colorectal cancer cohort from 25 institutions, we analyzed 1464 patients across all disease stages and tumor locations to determine the prevalence and clinicopathological features of MSI‐H/dMMR colorectal cancer. MSI‐H/dMMR tumors accounted for 9.4% of cases overall, were present in 22% of right‐sided colon cancers, and ...
Yoshihiro Morimoto, Mamoru Uemura, Yoshinori Kagawa, Hidekazu Takahashi, Masayuki Hiraki, Yozo Suzuki, Shinichi Yoshioka, Mitsuyoshi Tei, Shu Okamura, Yukako Mokutani, Atsushi Naito, Shinji Tokuyama, Takamichi Komori, Akinobu Yasuyama, Genta Sawada, Yujiro Fujie, Shinya Yamashita, Naotsugu Haraguchi, Yusuke Matsuura, Chu Matsuda, Yoshinao Chinen, Tatsushi Shingai, Katsuki Danno, Nobuo Tanaka, Kazuya Sakata, Kohei Murata, Yuichiro Doki, Hidetoshi Eguchi   +27 more
wiley   +1 more source

Building trust in the integration of artificial intelligence into chemical risk assessment: findings from the 2024 ECETOC workshop. [PDF]

Arch Toxicol
Gant TW, Boxall A, Burgwinkel D, Zare Jeddi M, Djidrovski I, Friedrichs S, Hardy B, Hartung T, Holland D, Karwath A, Kienhuis A, Kleinstreuer N, Lin Z, Marczylo EL, Marvuglia A, Qian H, van Ravenzwaay B, Rees P, Sarimveis H, Tralau T, Wilmot L, Zalewski A, Rouquié D.   +22 more
europepmc   +1 more source

Innovations in Gastric Cancer Surgery During Early Minimally Invasive Era and Future Perspectives

Annals of Gastroenterological Surgery, EarlyView.
With continuing revelations in tumor biology and the emergence of artificial intelligence, new horizons for surgical innovation are opening. At the center of this transformative journey stands the innovative surgeon, driven by passion, guided by data, and steadfast in the commitment to patient safety and quality of life.
Reut El‐On, Young‐Woo Kim
wiley   +1 more source

From Framework Inventory to Reporting Architecture: Next Steps for Dental AI Reporting Standards. [PDF]

Int Dent J
Mourão CF, Juliasse LE.
europepmc   +1 more source

A Solution for Exosome‐Based Analysis: Surface‐Enhanced Raman Spectroscopy and Artificial Intelligence

Advanced Intelligent Discovery, EarlyView.
Exosomes are emerging as powerful biomarkers for disease diagnosis and monitoring. This review highlights the integration of surface‐enhanced Raman spectroscopy with artificial intelligence to enhance molecular fingerprinting of exosomes. Machine learning and deep learning techniques improve spectral interpretation, enabling accurate classification of ...
Munevver Akdeniz, Zakarya Al‐Shaebi, Omer Aydin   +2 more
wiley   +1 more source

Mechanisms of SGLT inhibitor action and physiological mediators: systematic review and protocol for the MOSAIC collaborative meta-analysis. [PDF]

BMJ Open
Kugathasan L, Nardone M, Muskiet MHA, Diaz Martinez JP, Lovblom LE, Orchanian-Cheff A, Nielsen S, Rotbain V, Kazup A, Cersosimo E, Gullaksen S, Vernstrom L, van Baar MJB, van Bommel E, Kannenkeril D, Scholtes R, Hesp A, Mosterd C, Touw DJ, Lambers Heerspink H, Krebbe M, Joles J, Kvitne K, Laugesen E, Mose F, Mårup FH, Nieuwdorp M, Geist B, Maruyama S, Kato S, Kalambokis G, Tsiakas I, Jensen J, Schou M, Omar M, Kistorp CM, Perna A, Ruggenenti P, Persson F, Schmieder R, Singh S, van Raalte DH, Cherney D, Srinivasan Sridhar V.   +43 more
europepmc   +1 more source

The role of artificial intelligence in predicting COPD exacerbations using multimodal data: a systematic review. [PDF]

ERJ Open Res
Kapatais C, Karaoulani T, Papanikolaou A, Koukaki E, Bakakos A, Anagnostopoulou C, Papaioannou AI, Bakakos P, Rovina N.   +8 more
europepmc   +1 more source

UCCL-IKF-AIO-STO-0124 NeoART-an international phase Ib/II platform trial investigating trastuzumab deruxtecan (T-DXd) combined with neoadjuvant chemotherapy for HER2-positive, resectable esophagogastric adenocarcinoma (EGA). [PDF]

ESMO Gastrointest Oncol
Stocker G, Hacker UT, Obermannová RL, Ilhan-Mutlu A, Junge S, Pauligk C, Al-Batran SE, Goetze TO, Lordick F.   +8 more
europepmc   +1 more source